The latest data from the Nebraska Cancer Registry show that over 9,800 invasive cancers were diagnosed among Nebraska residents during 2015. Cancer was also Nebraska's second leading cause of death in 2015, ranking after heart disease, and accounting for over 3,490 deaths among Nebraska residents.
According to the data collected by the registry in 2015, the 10 most frequently diagnosed invasive cancers in Nebraska were:
The Nebraska Cancer Registry was created by the Nebraska Unicameral in 1986 and began collecting data in 1987. The purpose of the registry is to gather data that describe how many Nebraska residents are diagnosed with cancer, what types of cancer they have, how far the disease has spread at the time of diagnosis, what types of treatment they receive, and how long they survive after diagnosis. The Department of Health and Human Services uses these data to identify high-risk populations and monitor long-term disease trends, and also provides data upon request for research studies and public information. In recognition of the accuracy and completeness of the data that it has collected, the North American Association of Central Cancer Registries has awarded the Nebraska Cancer Registry its gold standard certificate of data quality for 19 consecutive years (1995-2013). The registry is supported with funds from the state's cigarette tax and the Centers for Disease Control and Prevention (CDC).
Much more of the latest data gathered by the Nebraska Cancer Registry are available in the reports Cancer Incidence and Mortality in Nebraska: 2015 and Cancer Incidence and Mortality in Nebraska Appendix 2015. However, this report does not include all of the data collected by the registry. To request data that are unavailable in the report, click on DHHS Data Request form - Aggregate data fillable, Instructions For Request For Data, Research Data Request, and the Confidentiality Agreement.
Below are a series of short documents that present the most current Nebraska statistics on cancer incidence, mortality, staging, and screening.